Bright Minds Biosciences
DRUG
#8901
Rank
S$0.27 B
Marketcap
S$27.61
Share price
-17.75%
Change (1 day)
-58.78%
Change (1 year)

Annual Reports (40-F)

Latest form 40-F annual reports for Bright Minds Biosciences CIK: 0001827401
The 40-F is the annual report that Canadian companies file with the SEC instead of a 10-K. It contains the annual information form, MD&A and financial statements of Bright Minds Biosciences

Thumbnail Bright Minds Biosciences 40-F Annual Report 2025

40-F Annual Report 2025

Language: English

View Annual Report (40-F)